Company Profile
Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T cell-based test technologies with the intention of providing an immunology profiling platform. T cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.
Latest Presentation
Industry Classifications
Sector:
Biotechnology
Industry:
In Vitro Diagnostics
NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:
In Vitro And In Vivo Diagnostic Substances (2835)
Contact Information
Investor Relations
Russo Partners, LLC
Nic Johnson
12 West 27th Street
4th Floor
New York, NY 10001
M: 303-482-6405
nic.johnson@russopartnersllc.com
Company Contact
Virax Biolabs Group Limited
BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire ML1 5UH
United Kingdom
T: +44 20 7788 7414
info@viraxbiolabs.com